SCHEMBL15926009

SCHEMBL15926009

CC(=O)OCCN=O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL178276 0.85
SCHEMBL68617 0.81 ALDH1A1 (0.50)
SCHEMBL1892583 0.79
SCHEMBL7659780 0.77 CHRM5 (0.50)
SCHEMBL64593 0.76 ALDH1A1 (0.68)
SCHEMBL17166586 0.75 ALDH1A1 (0.30)
SCHEMBL5692186 0.75
SCHEMBL28037055 0.74
SCHEMBL29446779 0.74 ALDH1A1 (0.65)
Ammonia Solution, Strong SCHEMBL5679172 0.74 ALDH1A1 (0.65)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2285775-B1 Lactams and their use in the treatment of inter alia ocular hypertension or baldness ALLERGAN INC (US) 2017-03-22 EP disclosed
EP-2504309-B1 Synthesis of acetoxyacetaldehyde LEK PHARMACEUTICALS (SI) 2014-08-06 EP disclosed